Unknown

Dataset Information

0

A computationally inspired in-vivo approach identifies a link between amygdalar transcriptional heterogeneity, socialization and anxiety.


ABSTRACT: Pharmaceutical breakthroughs for anxiety have been lackluster in the last half-century. Converging behavior and limbic molecular heterogeneity has the potential to revolutionize biomarker-driven interventions. However, current in vivo models too often deploy artificial systems including directed evolution, mutations and fear induction, which poorly mirror clinical manifestations. Here, we explore transcriptional heterogeneity of the amygdala in isogenic mice using an unbiased multi-dimensional computational approach that segregates intra-cohort reactions to moderate situational adversity and intersects it with high content molecular profiling. We show that while the computational approach stratifies known features of clinical anxiety including nitric oxide, opioid and corticotropin signaling, previously unrecognized druggable biomarkers emerge, such as calpain11 and scand1. Through ingenuity pathway analyses, we further describe a role for neurosteroid estradiol signaling, heat shock proteins, ubiquitin ligases and lipid metabolism. In addition, we report a remarkable behavioral pattern that maps to molecular features of anxiety in mice through counterphobic social attitudes, which manifest as increased, yet spatially distant socialization. These findings provide an unbiased approach for interrogating anxiolytics, and hint toward biomarkers underpinning behavioral and social patterns that merit further exploration.

SUBMITTER: Goldman A 

PROVIDER: S-EPMC6901550 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

A computationally inspired in-vivo approach identifies a link between amygdalar transcriptional heterogeneity, socialization and anxiety.

Goldman Aaron A   Smalley Joshua L JL   Mistry Meeta M   Krenzlin Harald H   Zhang Hong H   Dhawan Andrew A   Caldarone Barbara B   Moss Stephen J SJ   Silbersweig David A DA   Lawler Sean E SE   Braun Ilana M IM  

Translational psychiatry 20191209 1


Pharmaceutical breakthroughs for anxiety have been lackluster in the last half-century. Converging behavior and limbic molecular heterogeneity has the potential to revolutionize biomarker-driven interventions. However, current in vivo models too often deploy artificial systems including directed evolution, mutations and fear induction, which poorly mirror clinical manifestations. Here, we explore transcriptional heterogeneity of the amygdala in isogenic mice using an unbiased multi-dimensional c  ...[more]

Similar Datasets

2019-12-20 | GSE132457 | GEO
| PRJNA548130 | ENA
| S-EPMC4814306 | biostudies-literature
| S-EPMC4111803 | biostudies-literature
| S-EPMC5443782 | biostudies-literature
2023-11-22 | GSE240278 | GEO
| S-EPMC6008327 | biostudies-literature
| S-EPMC7733460 | biostudies-literature
| S-EPMC8340527 | biostudies-literature
| S-EPMC8340527 | biostudies-literature